Skip to content

Treatment for controlling blood sugar level in the patients with Type 2 Diabetes mellitus

A Double Blind RCT Study on the- Role of Virechanottara Jaya vati with Lodradi Kashaya Anupana and Neelakanta rasa with Phalatrikadi Kashaya Anupana in Madhumeha (T2DM)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045202
Enrollment
40
Registered
2022-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Taranath govt ayurvedic medical college and hospital bellary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with clinical features of Madhumeha(T2DM) will be selected. 1]Subjects with FBS 126mg/dl to 200 mg/dl. 2]Subjects with PPBS 160mg/dl to 400mg/dl. 3]Subjects with HbA1c 6.5% to 10%. 4]Subjects of either sex between the age group of 30 to 60 years. 5]Subjects who are fit for virechana. 6]Subjects irrespective of history of COVID-19.

Exclusion criteria

Exclusion criteria: 1]Subjects of Type I DM, 2]Diabetic patient in ICU, post surgery. 3]Pregnancy and Lactating women.

Design outcomes

Primary

MeasureTime frame
1]To decrease blood sugar level 2] Prevention of complication of t2dm Timepoint: 12 weeks

Secondary

MeasureTime frame
1]To decrease blood sugar level 2]Prevention of complication of t2DMTimepoint: 10 Week, 15 week

Countries

India

Contacts

Public ContactDr Fareeda Begum Shaikh
dr.fareedabegumshaikh@gmail.com9886478611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026